Log in

NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, Forecast & News

$42.60
+0.97 (+2.33 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$41.46
Now: $42.60
$43.04
50-Day Range
$40.14
MA: $46.35
$52.32
52-Week Range
$40.06
Now: $42.60
$77.00
Volume261,183 shs
Average Volume352,135 shs
Market Capitalization$945.93 million
P/E Ratio125.29
Dividend YieldN/A
Beta1.52
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. Read More…

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$204.27 million
Cash Flow$1.20 per share
Book Value$6.79 per share

Profitability

Net Income$-47,270,000.00

Miscellaneous

Employees952
Market Cap$945.93 million
Next Earnings Date2/27/2020 (Estimated)
OptionableOptionable

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.


Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) posted its quarterly earnings data on Thursday, November, 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01. The company had revenue of $74.27 million for the quarter, compared to the consensus estimate of $75.37 million. Tabula Rasa HealthCare had a positive return on equity of 0.50% and a negative net margin of 13.46%. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Tabula Rasa HealthCare.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $$282-285 million, compared to the consensus revenue estimate of $$289.21 million.

What price target have analysts set for TRHC?

7 brokers have issued twelve-month price objectives for Tabula Rasa HealthCare's stock. Their forecasts range from $58.00 to $88.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $73.62 in the next year. This suggests a possible upside of 72.8% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare.

What is the consensus analysts' recommendation for Tabula Rasa HealthCare?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating, 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.

Has Tabula Rasa HealthCare been receiving favorable news coverage?

Headlines about TRHC stock have trended somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Tabula Rasa HealthCare earned a coverage optimism score of 0.7 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Tabula Rasa HealthCare.

Who are some of Tabula Rasa HealthCare's key competitors?

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Canopy Growth (CGC), Adobe (ADBE), GW Pharmaceuticals PLC- (GWPH), Micron Technology (MU), Netflix (NFLX), QUALCOMM (QCOM), VMware (VMW), Align Technology (ALGN) and salesforce.com (CRM).

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 69)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 50)
  • Mr. Brian W. Adams, CFO & Sec. (Age 37)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (2.46%), Rice Hall James & Associates LLC (1.76%), Emerald Advisers LLC (1.75%), Emerald Mutual Fund Advisers Trust (1.48%), Peregrine Capital Management LLC (1.38%) and First Trust Advisors LP (1.30%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Growth Fund 1Q Lp Originate, Orsula V Knowlton and Samira Beckwith. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Which institutional investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Peregrine Capital Management LLC, Virginia Retirement Systems ET AL, Pictet Asset Management Ltd., Argyle Capital Management Inc., Eagle Asset Management Inc., Barclays PLC and Taylor Wealth Management Partners. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Orsula V Knowlton and Samira Beckwith. View Insider Buying and Selling for Tabula Rasa HealthCare.

Which institutional investors are buying Tabula Rasa HealthCare stock?

TRHC stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Point72 Asset Management L.P., Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, Handelsbanken Fonder AB, Lisanti Capital Growth LLC, Squarepoint Ops LLC and WCM Investment Management LLC. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $42.60.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $945.93 million and generates $204.27 million in revenue each year. The company earns $-47,270,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. Tabula Rasa HealthCare employs 952 workers across the globe.View Additional Information About Tabula Rasa HealthCare.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is http://www.tabularasahealthcare.com/.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (NASDAQ TRHC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  277 (Vote Outperform)
Underperform Votes:  255 (Vote Underperform)
Total Votes:  532
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Featured Article: Dividend Achievers

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel